NVO Health
Research cart Log In
Compounded

Sermorelin

Compounded sermorelin acetate

A peptide that prompts the pituitary to release more of your own growth hormone.

About Sermorelin

Sermorelin is a short copy of growth hormone-releasing hormone (GHRH). The FDA-approved brand, Geref, was discontinued by its maker, so it is now available only from compounding pharmacies. It is usually injected at bedtime.

Read the full Sermorelin guide: research, safety and sources →

How it works

  1. Complete a short online visit. Answer health questions on our telehealth partner's secure site. Some treatments need lab work first.
  2. A licensed provider reviews it. They decide whether Sermorelin is safe and appropriate for you and may message you with questions.
  3. If prescribed, it ships to you from a licensed U.S. pharmacy, with ongoing check-ins and refills through your provider.

Important safety information

Injection-site redness, flushing, headache and dizziness can occur. Not for people with active cancer. Compounded versions are not FDA approved, and FDA does not review them for safety, effectiveness or quality.

This is not a complete list. Your provider will review your health history, medicines and allergies before prescribing, and the pharmacy includes the full prescribing information.

Treatment is not guaranteed. NVO Health is not a healthcare provider. Care is provided by independent licensed providers who alone decide whether you are eligible and whether any treatment or prescription is medically appropriate. Completing an intake or paying a fee does not guarantee a visit, a prescription or a particular medication. Availability varies by state and patient. Not for emergencies: call 911. See the Telehealth Consent.
Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness or quality. They are prescribed only when an independent licensed provider decides they are appropriate for you, are dispensed by a licensed pharmacy, and may become unavailable as FDA guidance, pharmacy policy and state law change.